Topics

Eisai's Weight Loss Drug Belviq Pulled From Market Over Cancer Risk

19:00 EST 13 Feb 2020 | BioSpace

Eisai indicated it was voluntarily withdrawing the drug, but in a statement noted it disagreed with the FDA’s interpretation of the data and believes the drug’s benefits outweigh the cancer risk.

Original Article: Eisai's Weight Loss Drug Belviq Pulled From Market Over Cancer Risk

NEXT ARTICLE

More From BioPortfolio on "Eisai's Weight Loss Drug Belviq Pulled From Market Over Cancer Risk"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...